IPP Bureau
Transmural Systems wins breakthrough FDA nod for coronary-saving TAVR device
By IPP Bureau - November 27, 2025
The clearance for TELLTALE positions Transmural Systems at the forefront of next-generation electrosurgical solutions for structural heart interventions
Investors pile in as Cordance secures oversubscribed seed round for brain-cancer tech
By IPP Bureau - November 27, 2025
The fresh capital will propel Cordance into its first-in-human clinical trial
Glenmark launches world’s first nebulized triple therapy for COPD
By IPP Bureau - November 27, 2025
Clinical studies conducted in India demonstrated that this nebulized triple therapy rapidly improves lung function and offers better control of breathlessness
India’s pharma industry showcases innovation, global ambitions at CPHI & PMEC India 2025
By IPP Bureau - November 27, 2025
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
Novo Nordisk fast-tracks higher-dose obesity drug to FDA
By IPP Bureau - November 27, 2025
The drug, intended for chronic weight management alongside diet and exercise, is now under the FDA’s new CNPV expedited review pathway
Lords Mark bets big on AI-driven dialysis tech, buys 85% stake in Renalyx Health
By IPP Bureau - November 27, 2025
Renalyx will continue operating as an independent unit within the group
Dr. Lal PathLabs launches India's first complement testing lab
By IPP Bureau - November 27, 2025
The Complement Laboratory is equipped with state-of-the-art immunoturbidimetric and ELISA platforms and adheres to CAP and NABL accreditation standards
SMS Pharmaceutical's associate company receives FDA approval for reformulated Ranitidine
By IPP Bureau - November 27, 2025
The approval by the US FDA comes after extensive safety testing and manufacturing improvements
Zydus inks licensing, commercialisation pact with RK Pharma
By IPP Bureau - November 27, 2025
RK Pharma will manufacture and supply the finished product, while Zydus will be responsible for the NDA submission and commercialization of the product in the US
Dhoni joins Arth by Emcure to tackle iron deficiency on World Iron Deficiency Day
By IPP Bureau - November 27, 2025
FDA updates label for Sun Pharma’s UNLOXCYT, highlighting durable responses in advanced skin cancer
By IPP Bureau - November 27, 2025
The update reflects long-term clinical trial data showing that many patients with mCSCC or laCSCC experienced lasting responses
Novo Nordisk’s new diabetes combo drug delivers big wins in mid-stage trial
By IPP Bureau - November 26, 2025
The trial tested six injectable doses and three oral doses over as long as 36 weeks
Teva breaks ground with EU approval for two key bone disease biosimilars
By IPP Bureau - November 26, 2025
Bengaluru makes medical history with first robot-assisted deceased donor kidney transplant
By IPP Bureau - November 26, 2025
Deceased donor kidney transplants are time-critical, and it is uncommon to attempt them robotically
